Document Detail

4(R/S)-Guanidinylprolyl collagen peptides: On-resin synthesis, complexation with plasmid DNA and the role of peptides in enhancment of transfection.
MedLine Citation:
PMID:  22428628     Owner:  NLM     Status:  Publisher    
Chimeric collagen peptides containing cationic 4(R/S)-guanidinylproline are synthesized by in-situ amidinylation of 4(R/S)-aminoproline residues. These peptides uniquely enhance the transfection efficiency of GFP encoded plasmid DNA (pRmHa3-GFP) into cells through efficient DNA condensation resulting from non-specific electrostatic interactions of cationic guanidino groups and localise in sub-cytoplasmic organelles.
Manaswini Nanda; Krishna N Ganesh
Related Documents :
12595708 - Purification and crystallization of the n-terminal domain from the human doublecortin-l...
10623548 - The tertiary structure at 1.59 a resolution and the proposed amino acid sequence of a f...
1569568 - Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulat...
15753098 - Crystal structure of a nicotinate phosphoribosyltransferase from thermoplasma acidophilum.
17627488 - Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial netw...
8622978 - Defective dimerization of von willebrand factor subunits due to a cys-> arg mutation in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-19
Journal Detail:
Title:  The Journal of organic chemistry     Volume:  -     ISSN:  1520-6904     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985193R     Medline TA:  J Org Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical development of new treatments for diabetic macular oedema.
Next Document:  6 Months of "Temporary" Support by Levitronix Left Ventricular Assist Device.